RAPT Therapeutics Financial Overview
RAPT Therapeutics's market cap is currently $1.01B. The company's EPS TTM is $-0.65; its P/E ratio is ―; RAPT Therapeutics is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.75. See an overview of income statement, balance sheet, and cash flow financials.
